Ilan Shabat-Ben

Umea, AC, Sweden

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Exploring strategies for management of in-hospital stroke in Sweden: A qualitative study.

Exploring strategies for management of in-hospital stroke in Sweden: A qualitative study.

Journal: PloS one
Published: April 26, 2024

Characteristics of in-hospital stroke patients in Sweden: A nationwide register-based study.

Characteristics of in-hospital stroke patients in Sweden: A nationwide register-based study.

Journal: European stroke journal
Published: June 17, 2023

Ataxia Syndrome With Hearing Loss and Nephronophthisis Associated With a Novel Homozygous Variant in XPNPEP3.

Ataxia Syndrome With Hearing Loss and Nephronophthisis Associated With a Novel Homozygous Variant in XPNPEP3.

Journal: Neurology. Genetics
Published: June 07, 2023

The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.

The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion.

Journal: Annals of surgical oncology
Published: February 19, 2018

The effect of perfusate buffering on toxicity and response in isolated hepatic perfusion for uveal melanoma liver metastases.

The effect of perfusate buffering on toxicity and response in isolated hepatic perfusion for uveal melanoma liver metastases.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: January 24, 2017

Isolated limb perfusion as a treatment option for rare types of tumours.

Isolated limb perfusion as a treatment option for rare types of tumours.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: June 09, 2016

Erratum to: Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.

Erratum to: Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.

Journal: Annals of surgical oncology
Published: March 02, 2016

Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.

Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.

Journal: Annals of surgical oncology
Published: January 04, 2016

Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.

Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.

Journal: Annals of surgical oncology
Published: July 18, 2015

Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.

Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.

Journal: Annals of surgical oncology
Published: July 08, 2015

Melphalan, Antimelanoma Immunity, and Inflammation--Letter.

Melphalan, Antimelanoma Immunity, and Inflammation--Letter.

Journal: Cancer research
Published: May 01, 2015

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.

Journal: Journal of visualized experiments : JoVE
Published: February 05, 2015
Showing 1-12 of 12

Last Updated: 09/26/2026